These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17289875

  • 21. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA.
    Cancer; 2017 Oct 15; 123(20):3925-3932. PubMed ID: 28657667
    [Abstract] [Full Text] [Related]

  • 22. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A, Louchez MM, Fournier J, Gamoudi A, Rahal K, El May MV, El May A, Revillion F, Peyrat JP.
    Bull Cancer; 2014 Nov 15; 101(11):E36-40. PubMed ID: 25418591
    [Abstract] [Full Text] [Related]

  • 23. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
    Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ.
    Cancer Res; 2000 Mar 01; 60(5):1371-5. PubMed ID: 10728701
    [Abstract] [Full Text] [Related]

  • 24. The prevalence of BRCA2 mutations in familial pancreatic cancer.
    Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M, Rothenmund H, Gallinger S, Klein A, Petersen GM, Hruban RH.
    Cancer Epidemiol Biomarkers Prev; 2007 Feb 01; 16(2):342-6. PubMed ID: 17301269
    [Abstract] [Full Text] [Related]

  • 25. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
    Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K.
    Clin Cancer Res; 2010 Apr 01; 16(7):2115-21. PubMed ID: 20215531
    [Abstract] [Full Text] [Related]

  • 26. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 27. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL.
    Nat Genet; 1996 May 15; 13(1):123-5. PubMed ID: 8673091
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE, Lüleci G, Ozçelik T, Colak T, Schayek H, Akaydin M, Friedman E.
    Hum Mutat; 2003 Apr 15; 21(4):444-5. PubMed ID: 12655560
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
    Rökman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J.
    Am J Hum Genet; 2002 May 15; 70(5):1299-304. PubMed ID: 11941539
    [Abstract] [Full Text] [Related]

  • 33. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
    Antczak A, Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dębniak T, Masojć B, Górski B, Gromowski T, Nagorna A, Gołąb A, Sikorski A, Słojewski M, Gliniewicz B, Borkowski T, Borkowski A, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Domagała P, Stawicka M, Milecki P, Akbari MR, Narod SA, Lubiński J, Cybulski C, Polish Hereditary Prostate Cancer Consortium, Other members of the Polish Hereditary Prostate Cancer Consortium, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała W, Chosia M, van de Wetering T, Serrano-Fernández P, Puszyński M, Soczawa M, Switała J, Archimowicz S, Kordowski M, Zyczkowski M, Borówka A, Bagińska J, Krajka K, Szwiec M, Haus O, Janiszewska H, Stembalska A, Sąsiadek MM.
    Gene; 2013 Dec 15; 532(2):173-6. PubMed ID: 24096176
    [Abstract] [Full Text] [Related]

  • 34. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
    Laitman Y, Kaufman B, Lahad EL, Papa MZ, Friedman E.
    Isr Med Assoc J; 2007 Nov 15; 9(11):791-6. PubMed ID: 18085035
    [Abstract] [Full Text] [Related]

  • 35. Germline mutations in RAD51C in Jewish high cancer risk families.
    Kushnir A, Laitman Y, Shimon SP, Berger R, Friedman E.
    Breast Cancer Res Treat; 2012 Dec 15; 136(3):869-74. PubMed ID: 23117857
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A, Kavanagh L, Clouston D, Bolton D, kConFab Investigators, Fox S, Thorne H.
    BJU Int; 2012 Dec 15; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN.
    Bull Cancer; 2006 Sep 15; 93(9):841-6. PubMed ID: 16980226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.